SCHEMBL6407583

SCHEMBL6407583

COc1ccc(C(OCC2C(C(=O)Oc3c(C(C)(C)C)cc(C)cc3C(C)(C)C)C2(C)C)(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34
APEX1 P27695 1/20 0.34
MAPK1 P28482 1/20 0.34
RECQL P46063 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
SLC6A11 P48066 2/20 0.34
TNFRSF1A P19438 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
NPC1 O15118 1/20 0.33
EPHX2 P34913 1/20 0.33
RAB9A P51151 1/20 0.33
NR1H4 Q96RI1 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPT P10636 2/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408345 0.89 ELANE (0.32)
SCHEMBL6407225 0.84 MMP1 (0.37) TNFRSF1AMEN1KMT2ANPC1EPHX2
SCHEMBL6412775 0.81 SLC6A11 (0.36) LMNAALDH1A1ALOX15APEX1MAPK1
SCHEMBL6532218 0.80 ALDH1A1 (0.40) LMNAALDH1A1ALOX15APEX1MAPK1
SCHEMBL6407457 0.80 ALDH1A1 (0.37) LMNAALDH1A1ALOX15APEX1MAPK1
SCHEMBL6411371 0.80 ALDH1A1 (0.41) LMNAALDH1A1HSD17B10SLC6A11MEN1
SCHEMBL6412672 0.79 S1PR1 (0.37) ALDH1A1MAPK1TDP1MEN1KMT2A
SCHEMBL6406883 0.78 SLC6A11 (0.39) SLC6A11MEN1KMT2ATP53CYP1A2
SCHEMBL6409595 0.78 SLC6A11 (0.39) SLC6A11MEN1KMT2ATP53CYP1A2
SCHEMBL6412629 0.78 SLC6A11 (0.36) SLC6A11TNFRSF1AMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 LMNA 3772/4885ALDH1A1 601/4885ALOX15 491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.